Episurf Medical ABOMXSTO: EPIS_B

EPIS_B: US growth and cost savings drive improved results, but financing uncertainty persists

· Issued by Episurf Medical AB

US gross order intake and customer base grew sharply in Q3 2025, driving improved financial results and reduced losses. Regulatory progress for the MTP implant continues, with a focus on US market expansion and cost-saving measures. Material uncertainty remains due to unsecure near-term financing.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Episurf Medical AB on 6ix

Earlier from Episurf Medical

Later from Episurf Medical

All Episurf Medical news releases